AI Verdict
OKTA has stronger fundamentals based on our AI analysis.
OKUR vs OKTA Fundamental Comparison
| Metric | OKUR | OKTA |
|---|---|---|
| Revenue | $3.4M | $2.9B |
| Net Income | $-59.5M | $235.0M |
| Net Margin | -1,733.7% | 8.1% |
| ROE | -105.9% | 3.4% |
| ROA | -95.8% | 2.4% |
| Current Ratio | 10.28x | 1.43x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-4.40 | $1.31 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
OKUR vs OKTA: Frequently Asked Questions
Is OKUR or OKTA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), OKTA has stronger fundamentals. OKUR is rated SELL (75% confidence) while OKTA is rated HOLD (72% confidence). This is not investment advice.
How does OKUR compare to OKTA fundamentally?
OnKure Therapeutics, Inc. has ROE of -105.9% vs Okta, Inc.'s 3.4%. Net margins are -1,733.7% vs 8.1% respectively.
Which stock pays higher dividends, OKUR or OKTA?
OKUR has a dividend yield of N/A or no dividend while OKTA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in OKUR or OKTA for long term?
For long-term investing, consider that OKUR has SELL rating with 75% confidence, while OKTA has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about OKUR vs OKTA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OKUR vs OKTA, the AI consensus favors OKTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.